Digital - Optellum

GE, Optellum Join Hands To Boost Advance Lung Cancer Diagnosis With AI

Post published:November 26, 2021
Post category:Media

Nasdaq.com Reporter: RTTNnews.com

GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Post published:November 26, 2021
Post category:Media

Guru Focus

Top Story GE Healthcare, Optellum partner up for AI-driven lung cancer diagnosis

Post published:November 26, 2021
Post category:Media

FirstWord HealthTech Reporter: Tina Tan

GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Post published:November 26, 2021
Post category:Media

Chronicle Tribune

GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Post published:November 26, 2021
Post category:Media

BioSpace

GE Healthcare advances lung cancer diagnosis with AI

Post published:November 26, 2021
Post category:Media

Bio Spectrum India

Optellum, Johnson & Johnson Launch Strategic Collaboration in Lung Cancer

Post published:September 26, 2021
Post category:Media

Onclive

Biopharma AI Collaborations Driving Innovative Change in Drug Development

Post published:September 13, 2021
Post category:Media

BioSpace

Biopharma AI Collaborations Driving Innovative Change in Drug Development

Post published:September 13, 2021
Post category:Media

BioPharmaLive

J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech

Post published:August 26, 2021
Post category:Media

PharmaPhorum is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.PharmaPhorum

J&J teams up with Optellum to improve lung cancer survival rates

Post published:August 26, 2021
Post category:Media

EPM’s in-depth journalism drives the conversation on topics shaping the pharma and biopharma industries, from clinical trial to mass production, regulations, and logistics and distribution. EPM delivers the insight, news,…

Optellum collaborating with J&J

Post published:August 23, 2021
Post category:Media

Thames Valley BiotechNewsletter